IL145525A0 - Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines - Google Patents

Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines

Info

Publication number
IL145525A0
IL145525A0 IL14552599A IL14552500A IL145525A0 IL 145525 A0 IL145525 A0 IL 145525A0 IL 14552599 A IL14552599 A IL 14552599A IL 14552500 A IL14552500 A IL 14552500A IL 145525 A0 IL145525 A0 IL 145525A0
Authority
IL
Israel
Prior art keywords
alkyl
dihydroprolines
dehydropiperidines
producing
hydrogen
Prior art date
Application number
IL14552599A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL145525A0 publication Critical patent/IL145525A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14552599A 1999-03-26 2000-03-17 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines IL145525A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913699A DE19913699A1 (de) 1999-03-26 1999-03-26 Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen
PCT/EP2000/002377 WO2000058284A1 (de) 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4 - dehydroprolin und n-acyl-3,4 - dehydropiperidin-2-carbonsäure derivaten

Publications (1)

Publication Number Publication Date
IL145525A0 true IL145525A0 (en) 2002-06-30

Family

ID=7902464

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14552599A IL145525A0 (en) 1999-03-26 2000-03-17 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines

Country Status (22)

Country Link
US (1) US6579971B1 (enExample)
EP (1) EP1165509B1 (enExample)
JP (1) JP3868210B2 (enExample)
KR (1) KR20010104730A (enExample)
CN (1) CN1345310A (enExample)
AT (1) ATE278665T1 (enExample)
AU (1) AU3962500A (enExample)
BR (1) BR0009330A (enExample)
CA (1) CA2368479C (enExample)
CZ (1) CZ20013456A3 (enExample)
DE (2) DE19913699A1 (enExample)
ES (1) ES2230088T3 (enExample)
HK (1) HK1045156A1 (enExample)
HU (1) HUP0200420A2 (enExample)
IL (1) IL145525A0 (enExample)
MX (1) MXPA01009679A (enExample)
NO (1) NO20014645L (enExample)
RU (1) RU2001129097A (enExample)
TR (1) TR200102747T2 (enExample)
TW (1) TWI276626B (enExample)
WO (1) WO2000058284A1 (enExample)
ZA (1) ZA200107629B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396666C (zh) * 2005-12-14 2008-06-25 郑州大学 (4s)-1-叔丁氧羰基-4-氨基-l-脯氨酸乙酯及其合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
DE59409568D1 (de) 1993-09-09 2000-11-30 Schering Ag Wirkstoffe und gas enthaltende mikropartikel
DE19630082A1 (de) * 1996-07-26 1998-01-29 Basf Ag Verfahren zur Herstellung von 3-Pyrrolin-2-carbonsäure-Derivaten
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
DE19723473A1 (de) * 1997-06-04 1998-12-10 Basf Ag Verfahren zur Herstellung von chiralen 3,4-Didehydroprolinen
AU753196B2 (en) 1998-02-09 2002-10-10 Bracco Research S.A. Targeted delivery of biologically active media

Also Published As

Publication number Publication date
EP1165509B1 (de) 2004-10-06
BR0009330A (pt) 2002-01-08
RU2001129097A (ru) 2004-03-20
NO20014645D0 (no) 2001-09-25
US6579971B1 (en) 2003-06-17
KR20010104730A (ko) 2001-11-26
JP2002540190A (ja) 2002-11-26
DE50008117D1 (de) 2004-11-11
TR200102747T2 (tr) 2002-02-21
CA2368479C (en) 2005-03-01
NO20014645L (no) 2001-09-25
JP3868210B2 (ja) 2007-01-17
CN1345310A (zh) 2002-04-17
AU3962500A (en) 2000-10-16
CA2368479A1 (en) 2000-10-05
ATE278665T1 (de) 2004-10-15
DE19913699A1 (de) 2000-09-28
ES2230088T3 (es) 2005-05-01
TWI276626B (en) 2007-03-21
MXPA01009679A (es) 2002-03-14
WO2000058284A1 (de) 2000-10-05
CZ20013456A3 (cs) 2002-05-15
HK1045156A1 (zh) 2002-11-15
ZA200107629B (en) 2002-09-17
HUP0200420A2 (hu) 2002-05-29
EP1165509A1 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
TW197936B (enExample)
EP0484240A3 (en) Process for preparing hydrogen gas using microorganism
AU6001994A (en) Conversion of carbon or carbonated compounds in a plasma
AU6350699A (en) Chemical compounds
AU2383000A (en) Process for deactivation of polyolefin compositions utilizing carbon dioxide as a deactivation agent
MY119303A (en) New manufacturing process of metoprolol
IL145525A0 (en) Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines
AU4304696A (en) Process for preparing aliphatic alpha,omega-aminonitriles
AU684327B2 (en) Bridged cyclopentadienylmagnesium compounds and process for the preparation thereof and use thereof for preparing metallocenes
HU9301931D0 (en) Process for the production of azabicyclo [2.2.2] octane-3-imines and thereof inrtermediers
TW360658B (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
AU6699600A (en) Formulations of fluorescent whitening agents
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
MXPA02009846A (es) Proceso para preparar 6-aminocaproamida.
HU911261D0 (en) Process for preparing working solutions serving for production alkyl-tetrahydro-anthraquinones and hydrogen-peroxide containing this compound by means of anthraquinone procedure
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.
GB2333294A (en) Cytokine production inhibitors
MY122830A (en) Process for the preparation of (alpha)-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
IL97040A0 (en) Novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
NZ284474A (en) Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
HU9904315D0 (en) Process for preparing orthoesters
CA2370145A1 (en) Process of preparing a high-energy softening agent
ES2019010A6 (es) Un procedimiento de resolucion optica de dropropizina racemica.
PL348672A1 (en) Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates
AU3902000A (en) Method of making a bulk catalyst

Legal Events

Date Code Title Description
HP Change in proprietorship
KB Patent renewed
ERR Corrigendum

Free format text: IN JOURNAL 11/2005 P. 4812 PATENT APPLICATION NO. 145525 CORRECT FILING DATE TO 17.03.2000